Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Jodele S, Licht C, Goebel J, Dixon BP, Zhang K, Sivakumaran TA, Davies SM, Pluthero FG, Lu L, Laskin BL.

Blood. 2013 Sep 19;122(12):2003-7. doi: 10.1182/blood-2013-05-501445. Epub 2013 Jun 27.

2.

Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Jodele S, Fukuda T, Vinks A, Mizuno K, Laskin BL, Goebel J, Dixon BP, Teusink A, Pluthero FG, Lu L, Licht C, Davies SM.

Biol Blood Marrow Transplant. 2014 Apr;20(4):518-25. doi: 10.1016/j.bbmt.2013.12.565. Epub 2013 Dec 25.

3.

TMA: beware of complements.

Ricklin D, Cines DB.

Blood. 2013 Sep 19;122(12):1997-9. doi: 10.1182/blood-2013-07-512707.

4.
5.

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.

Sakamoto K, Imamura T, Osone S, Nishimura A, Nishida M, Ishida H, Hosoi H.

Pediatr Transplant. 2015 Jun;19(4):E97-100. doi: 10.1111/petr.12450. Epub 2015 Mar 4.

PMID:
25735190
6.

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.

Jodele S, Fukuda T, Mizuno K, Vinks AA, Laskin BL, Goebel J, Dixon BP, Chima RS, Hirsch R, Teusink A, Lazear D, Lane A, Myers KC, Dandoy CE, Davies SM.

Biol Blood Marrow Transplant. 2016 Feb;22(2):307-315. doi: 10.1016/j.bbmt.2015.10.002. Epub 2015 Oct 9.

7.

Complement activation in diseases presenting with thrombotic microangiopathy.

Meri S.

Eur J Intern Med. 2013 Sep;24(6):496-502. doi: 10.1016/j.ejim.2013.05.009. Epub 2013 Jun 4. Review.

PMID:
23743117
8.

A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury.

Jodele S, Laskin BL, Dandoy CE, Myers KC, El-Bietar J, Davies SM, Goebel J, Dixon BP.

Blood Rev. 2015 May;29(3):191-204. doi: 10.1016/j.blre.2014.11.001. Epub 2014 Nov 28. Review.

9.

Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Laskin BL, Maisel J, Goebel J, Yin HJ, Luo G, Khoury JC, Davies SM, Jodele S.

Transplantation. 2013 Jul 27;96(2):217-23. doi: 10.1097/TP.0b013e31829807aa.

10.

New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.

Jodele S, Dandoy CE, Myers KC, El-Bietar J, Nelson A, Wallace G, Laskin BL.

Transfus Apher Sci. 2016 Apr;54(2):181-90. doi: 10.1016/j.transci.2016.04.007. Epub 2016 Apr 25. Review.

PMID:
27156964
11.

Thrombotic microangiopathies: from animal models to human disease and cure.

Caprioli J, Remuzzi G, Noris M.

Contrib Nephrol. 2011;169:337-50. doi: 10.1159/000314579. Epub 2011 Jan 20.

PMID:
21252531
12.

[Diagnosis and treatment of microangiopathic hemolytic anemia].

Morishita E.

Rinsho Ketsueki. 2015 Jul;56(7):795-806. doi: 10.11406/rinketsu.56.795. Japanese.

PMID:
26251142
13.

The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy.

Jodele S, Zhang K, Zou F, Laskin B, Dandoy CE, Myers KC, Lane A, Meller J, Medvedovic M, Chen J, Davies SM.

Blood. 2016 Feb 25;127(8):989-96. doi: 10.1182/blood-2015-08-663435. Epub 2015 Nov 24.

14.

Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.

Jodele S, Davies SM, Lane A, Khoury J, Dandoy C, Goebel J, Myers K, Grimley M, Bleesing J, El-Bietar J, Wallace G, Chima RS, Paff Z, Laskin BL.

Blood. 2014 Jul 24;124(4):645-53. doi: 10.1182/blood-2014-03-564997. Epub 2014 May 29.

15.

Thrombotic microangiopathy: new insights.

Benz K, Amann K.

Curr Opin Nephrol Hypertens. 2010 May;19(3):242-7. doi: 10.1097/MNH.0b013e3283378f25. Review.

PMID:
20186056
16.

Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.

de Fontbrune FS, Galambrun C, Sirvent A, Huynh A, Faguer S, Nguyen S, Bay JO, Neven B, Moussi J, Simon L, Xhaard A, Resche-Riggon M, O'Meara A, Fremeaux-Bacchi V, Veyradier A, Socié G, Coppo P, de Latour RP.

Transplantation. 2015 Sep;99(9):1953-9. doi: 10.1097/TP.0000000000000601.

PMID:
25651309
17.

Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.

Arai Y, Yamashita K, Mizugishi K, Watanabe T, Sakamoto S, Kitano T, Kondo T, Kawabata H, Kadowaki N, Takaori-Kondo A.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1683-9. doi: 10.1016/j.bbmt.2013.09.005. Epub 2013 Sep 19.

18.

Thrombotic microangiopathy after kidney transplantation.

Noris M, Remuzzi G.

Am J Transplant. 2010 Jul;10(7):1517-23. doi: 10.1111/j.1600-6143.2010.03156.x.

19.

Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.

Jodele S, Bleesing JJ, Mehta PA, Filipovich AH, Laskin BL, Goebel J, Pinkard SL, Davies SM.

Pediatr Transplant. 2012 Mar;16(2):E39-42. doi: 10.1111/j.1399-3046.2010.01408.x. Epub 2010 Nov 5.

PMID:
21054715
20.

Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Jodele S, Hirsch R, Laskin B, Davies S, Witte D, Chima R.

Biol Blood Marrow Transplant. 2013 Feb;19(2):202-7. doi: 10.1016/j.bbmt.2012.08.022. Epub 2012 Sep 6.

Supplemental Content

Support Center